Venetoclax and hypomethylating agents versus other therapies: an international, multicenter, retrospective cohort chart review study
Jacqueline S. Garcia(Dana-Farber Cancer Institute), Aaron D. Goldberg(Memorial Sloan Kettering Cancer Center), Tsila Zuckerman(Johannes Gutenberg University Mainz), Boaz Nachmias, Xenia Schmidt(AbbVie (United States)), Joshua F. Zeidner(University of North Carolina at Chapel Hill), Yanqing Xu(AbbVie (United States)), David Levitz(Montefiore Medical Center), Melissa Montez, Evan C. Chen(Dana-Farber Cancer Institute), D. Pollyea(University of Colorado Denver), Lee Mozessohn(Sunnybrook Health Science Centre), Kaitlyn Easson, Yakir Moshe(Tel Aviv University), Thomas W. LeBlanc(Duke University), Moshe Grunspan(Weizmann Institute of Science), M. Levesque-Leroux, Chia-Wei Lin, Annie Guérin(Group for Research in Decision Analysis), Kaylee Miu(AbbVie (United States)), Esprit Ma, Marina Konopleva(Albert Einstein College of Medicine), Kendra Sweet(Moffitt Cancer Center), Pankit Vachhani(University of Alabama at Birmingham), P Desai(Cornell University), Marin Xavier(Scripps MD Anderson Cancer Center), Maximilian Stahl(Yale Cancer Center), Sameem Abedin(Medical College of Wisconsin), Rebecca Burne, Catherine Lai(Georgetown University), Cat N. Bui(AbbVie (United States)), Eugene Baraka, Ofir Wolach(Tel Aviv University)
Cited by 0
Related Papers
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859
Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation
|JAMA|2016|388
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
|Cancer Cell|2016|304
Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline
|Journal of Clinical Oncology|2022|256